New Prostate Cancer Treatment Modalities: Investigators: Dino Di Carlo; Owen Witte New research enabled by the Elman Family Foundation Innovation Fund aims at furthering treatment approaches for prostate cancer that employ engineered T cells of the immune system is helmed by Dino Di Carlo, the Armond and Elena Hairapetian Professor of Engineering and Medicine. Applying his technology for sorting single cells and capturing their secretions, the researchers are developing a method to quickly screen T cells for potency in targeting a protein specific to prostate tumor cells. The Elman Family Foundation Innovation Fund (formerly the Noble Family Innovation Fund), established with a $10 million philanthropic commitment to the California NanoSystems Institute at UCLA, supports basic and translational research involving interactions on the nanoscale — measured in billionths of a meter. Funding is earmarked for projects with substantial promise for commercialization and societal impact. The goal is to create a model for academic research and entrepreneurship that enables strategic investment to seed discoveries that have the potential to be translated for the public good. For more information about the fund use the link below: https://cnsi.ucla.edu/elman-fund/